According to a recent report published by WHO on 05/23/2018, the death toll of the Ebola epidemic in the northwest Democratic Republic of the Congo on May 20 is 27 – out of 58 confirmed or suspected cases. The public health risk can be considered high due to its potential to spread into urban areas and neighboring countries.
The latest on Inserm’s commitment to fighting this epidemic.
Inserm and its partners at Aviesan have created REACTing, a multidisciplinary consortium bringing together research groups and laboratories of excellence in order to prepare and coordinate research to combat the health crises linked to emerging infectious diseases.
In order to be better prepared for and help contain future Ebola epidemics, it is also essential to continue research into the vaccination strategy for preventing this fever.
Yazdan Yazdanpanah
Director of the Immunology, inflammation, infectious diseases and microbiology ITMO
Coordinator of the REACTing consortium
+33 (0)1 44 23 60 08
yazdan.yazdanpanah@inserm.fr
Cellphone number on request from the Inserm press room